EUVIMEDOpdag EUVIMED
Crossref

Evaluating Traumagel hemostatic device in a porcine femoral artery hemorrhage model

Jesse Q Nguyen iD, Irasema Terrazas, Jennifer Ybarra, Casey E Niland, Zoe V Bragg, Nathan C Mattheis, Thomas Edwards

Transfusion · 2026-05 · 66 (S1)

DOI: 10.1111/trf.70134 ↗

At a glance

Journal article in Transfusion, published online on 2026-03-06. Written by Jesse Q Nguyen and 6 co-authors. Institution: Hemorrhage Control and Vascular Dysfunction Department, United States Army Institute of Surgical Research, San Antonio, Texas, USA. Major MEDLINE topics: Femoral Artery, Hemorrhage, Hemostatics, Hemostatic Techniques. Cited 1 times so far (Crossref); 21 references. Funded by: Cresilon.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Compressible hemorrhage is an ongoing risk occurring in both civilian and combat prehospital settings. Because the prehospital setting is always changing, there is a need for continued development and innovations in hemorrhage control. Traumagel® is a hemostatic gel‐based device FDA approved for temporary external use for controlling moderate to severe bleeding. In this study, we compared the hemorrhage control efficacy of Traumagel to Combat Gauze and XSTAT ( N = 7 per group) in a porcine junctional hemorrhage model. Study design and methods Female Yorkshire were first anesthetized, then the femoral artery received an arteriotomy, and a 45 s uncontrolled hemorrhage occurred before treatment was applied. Animals were monitored for up to 4 h or until euthanasia criteria were met.

Results

Traumagel and Combat Gauze treatment groups demonstrated 71.4% survival, and the XSTAT treated group demonstrated 85.7% survival. Traumagel mean posttreatment blood loss was significantly higher than XSTAT ( p = .0307). Ranking by mean summation of complete hemostasis (min) was XSTAT (109.6 ± 45.89), Combat Gauze (86.14 ± 40.34), and Traumagel (33.27 ± 21.26).

Discussion

There were no differences in the overall survival duration between Traumagel, Combat Gauze, and XSTAT. Despite the higher posttreatment blood loss compared to Combat Gauze and XSTAT, Traumagel application is the fastest and its form factor conforms better to the wound site. XSTAT is the most effective intervention tested for reduced hemorrhage volume in a porcine femoral artery injury.

Subjects

MeSH terms (MEDLINE)

Femoral ArteryHemorrhageHemostaticsHemostatic TechniquesAnimalsFemaleSwineDisease Models, Animal

Author keywords

Traumagelcompressible hemorrhagehemorrhage controlporcine model

Substances

Hemostatics

Authors and institutions

  • Hemorrhage Control and Vascular Dysfunction Department, United States Army Institute of Surgical Research, San Antonio, Texas, USA.

ORCID profiles: Jesse Q Nguyen

Funding

  • Cresilon

Cite

APA

Nguyen, J. Q., Terrazas, I., Ybarra, J., Niland, C. E., Bragg, Z. V., Mattheis, N. C., & Edwards, T. (2026). Evaluating Traumagel hemostatic device in a porcine femoral artery hemorrhage model. Transfusion, 66(S1). https://doi.org/10.1111/trf.70134

Vancouver

Nguyen JQ, Terrazas I, Ybarra J, Niland CE, Bragg ZV, Mattheis NC, et al. Evaluating Traumagel hemostatic device in a porcine femoral artery hemorrhage model. Transfusion. 2026;66(S1). doi:10.1111/trf.70134

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Jesse Q and Terrazas, Irasema and Ybarra, Jennifer and Niland, Casey E and Bragg, Zoe V and Mattheis, Nathan C and Edwards, Thomas},
  title = {Evaluating Traumagel hemostatic device in a porcine femoral artery hemorrhage model},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {S1},
  doi = {10.1111/trf.70134}
}
Start for free →